Christopher Bowden
2018
Compensation breakdown
| Non-Equity Incentive Plan | $262,767 |
|---|---|
| Option Awards | $1,746,517 |
| Salary | $467,141 |
| Stock Awards | $641,025 |
| Other | $11,280 |
| Total | $3,128,730 |
Bowden received $1.7M in option awards, accounting for 56% of the total pay in 2018.
Bowden also received $262.8K in non-equity incentive plan, $467.1K in salary, $641K in stock awards and $11.3K in other compensation.
Rankings
In 2018, Christopher Bowden's compensation ranked 3,694th out of 14,244 executives tracked by ExecPay. In other words, Bowden earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,694 out of 14,244 | 74th |
Division Manufacturing | 1,371 out of 5,759 | 76th |
Major group Chemicals And Allied Products | 485 out of 2,122 | 77th |
Industry group Drugs | 404 out of 1,811 | 78th |
Industry Pharmaceutical Preparations | 312 out of 1,385 | 78th |
Pay ratio
| Christopher Bowden's Pay | $3,128,730 |
|---|---|
| Median Employee's Pay | $345,181 |
| Pay Ratio | 9to 1 |
In 2018, the annual total compensation of Christopher Bowden was $3,128,730.
The annual total compensation of the median employee at Agios Pharmaceuticals was $345,181.
The ratio of Christopher Bowden's pay to the pay of median employee was therefore 9 to one.
Bowden's colleagues
We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2018.
News
April 28, 2022
April 8, 2021
April 16, 2020
April 18, 2019